Amgen Inc.
AMGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $152 | $150 | $168 | $141 |
| - Cash | $9 | $8 | $9 | $12 |
| + Debt | $55 | $56 | $57 | $60 |
| Enterprise Value | $197 | $198 | $216 | $189 |
| Revenue | $10 | $9 | $8 | $9 |
| % Growth | 4.3% | 12.5% | -10.3% | – |
| Gross Profit | $6 | $6 | $5 | $6 |
| % Margin | 67.8% | 67.2% | 63.6% | 65.7% |
| EBITDA | $6 | $4 | $4 | $3 |
| % Margin | 61.9% | 39.5% | 50.1% | 32.2% |
| Net Income | $3 | $1 | $2 | $1 |
| % Margin | 33.7% | 15.6% | 21.2% | 6.9% |
| EPS Diluted | 5.93 | 2.65 | 3.2 | 1.16 |
| % Growth | 123.8% | -17.2% | 175.9% | – |
| Operating Cash Flow | $5 | $2 | $1 | $5 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $4 | $2 | $1 | $4 |